Health Care Supplies

ZHYL

ZHYL released FY2025 Q4 earnings on April 26 After-Market (BJT), actual revenue CNY 509.55 M, actual EPS CNY -0.2342

ZHYL released FY2026 Q1 earnings on April 26 After-Market (BJT), actual revenue CNY 601.92 M, actual EPS CNY 0.0115

ZHYL released FY2025 earnings on April 26 After-Market (BJT), actual revenue CNY 2.373 B (forecast CNY 2.739 B), actual EPS CNY -0.26

ZHYL FY2026 Q1 Earnings Release Scheduled for April 27 After-Market BJT

ZHYL to release FY2025 earnings on April 27 After-Market (BJT), forecast revenue CNY 2.739 B

ZHYL released FY2025 Q3 earnings on October 28 After-Market (BJT), actual revenue CNY 626.12 M, actual EPS CNY -0.0306

ZHYL released FY2025 9 Months Earnings on October 28 After-Market (BJT), actual revenue CNY 1.864 B, actual EPS CNY -0.0169

ZHYL FY2025 Q3 Earnings Release Scheduled for October 29, After-Market BJT

ZHYL released FY2025 Semi-Annual Earnings on August 27 After-Market (BJT), actual revenue CNY 1.238 B, actual EPS CNY 0.0133

ZHYL released FY2025 Q2 earnings on August 27 After-Market (BJT), actual revenue CNY 608.38 M, actual EPS CNY -0.0306

ZHYL to Release FY2025 Semi-Annual Earnings on August 28, 2025 (BJT)

Zhonghong Medical's subsidiary obtains medical device registration certificate

Subsidiaries of Zhonghong Medical Acquire SEA3 at a Low Price

Zhonghong Medical Subsidiary Acquires 75% Stake in Southeast Asia SEA3 Company

Zhonghong Medical Responds to Innovation Business Layout and Profit Growth

Zhonghong Medical's Secretary Responds to Low Gross Margin and Tariff Policy Impact

Zhonghong Medical to Invest in Glove Production Line Project

Zhonghong Medical's Subsidiary Maideren Obtains Medical Device Registration Certificate

Zhonghong Medical Holds Earnings Briefing

Zhonghong Medical's subsidiary obtains medical device change registration document

301122

300453

002382

300677

300981

002950

A-share medical consumables stocks continue to rise, ZHYL and INTCO are approaching a 20% limit-up, Allmed Medical and BLUE SAIL MEDICAL previously hit the limit-up, Sanxin Medtec and CAINA have leading gains

Wallstreetcn

CAINA

Sanxin Medtec

BLUE SAIL MEDICAL

INTCO

Allmed Medical

ZHYL announced that from September 22, 2025, to October 30, 2025, the company's general manager, Ms. Yang Hao, cumulatively increased her holdings by 50,000 shares through the centralized bidding method on the Shenzhen Stock Exchange, accounting for 0.0117% of the company's shares excluding those in the repurchase special account, with an increase amount of 661,300 yuan. This increase plan has been completed

Zhitong

ZHYL: General Manager Yang Hao has increased his holdings by 0.0117%

301097

002901

688108

688026

603880

The medical consumables sector has undergone significant adjustments, with SINOMED hitting the limit down, and Tianyi Medical, Double Medical, Guoke Hengtai, ZHYL, Jet Bio-Filtration, and NANFANG MEDICAL also following suit

Tianyi Medical

Double Medical

SINOMED

Jet Bio-Filtration

NANFANG MEDICAL

The medical consumables sector has undergone significant adjustments, with SINOMED hitting the limit down

ZHYL's subsidiary, ZHYL Medical Supplies Co., Ltd., has obtained a medical device registration certificate issued by the Hainan Provincial Drug Administration, involving disposable nutrition pump tubes, with a registration validity period from October 14, 2025, to October 13, 2030. The acquisition of this registration certificate will enrich the company's product variety in the field of nutrition pump consumables, enhance brand and technological advantages, and improve the overall competitiveness of the company and its subsidiaries

ZHYL: Subsidiary obtains medical device registration certificate

ZHYL's subsidiary Kelong Medical participated in the centralized procurement project for disposable pressure extension tubes and syringes in Zhangzhou City, Fujian Province, and some products are expected to be selected

ZHYL's subsidiary Kelun Medical Devices plans to be selected for the centralized procurement project

ZHYL announced that the company's general manager Yang Hao plans to increase his holdings of the company's shares through a centralized bidding method on the Shenzhen Stock Exchange within 6 months from the date of the announcement. The planned increase is not less than 50,000 shares, with no price range set. The funding source will be self-owned funds, and the increased shares will be locked for 6 months after the purchase is completed

ZHYL: The general manager plans to increase holdings of no less than 50,000 shares

ZHYL announced that in the first half of 2025, operating revenue was 1.238 billion yuan, a year-on-year increase of 7.76%. Net profit was 5.7429 million yuan, a year-on-year decrease of 82.35%. The company plans not to distribute cash dividends, not to issue bonus shares, and not to convert reserves into share capital

ZHYL: Net profit of 5.7429 million yuan in the first half of 2025, a year-on-year decrease of 82.35%

Recently, ZHYL's vacuum blood collection tube products won the bid for the seventh and eighth rounds of medical consumables procurement project in Jiangsu Province

ZHYL won the bid for the seventh and eighth rounds of medical consumables continuous procurement project in Jiangsu Province

ZHYL's subsidiary Jiangxi Kelong Medical Device Manufacturing Co., Ltd. participated in the centralized procurement projects in Jiangsu Province and Shaanxi Province, and some products are expected to be selected in the bidding

ZHYL's subsidiary participates in centralized procurement project and is expected to be selected

301363

300753

688580

603987

300289

Leadman and MaiLand rose over 10%, Shangrong Medical hit the daily limit, Lepu Medical, MeHow, ZHYL, VISHEE, APON, KDL, and several other stocks rose over 5%

ZHYL(300981.SZ)